✦ LIBER ✦

Ifosfamide in the treatment of recurrent or disseminated lung cancer A phase II study of two dose schedules

✍ Scribed by Dr. John J. Costanzi; Robert Gagliano; Demetrius Loukas; Frank J. Panettiere; James A. Hokanson

Publisher: John Wiley and Sons
Year: 1978
Tongue: English
Weight: 369 KB
Volume: 41
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(197805)41:5<1715::aid-cncr2820410510>3.0.co;2-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase II study of idarubicin in the tr

A phase II study of idarubicin in the treatment of measurable gastric cancer

✍ Ronald Maccormick; Geralynn Hirsch; Sunil Gupta; Pat Shannon; Lorne Rotstein 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 165 KB 👁 2 views

Idarubicin is one of the new anthracycline analogues. It has a higher therapeutic index than either doxorubicin or daunorubicin in a variety of murine leukemias and solid tumors. The authors performed a multicenter Phase II trial of idarubicin in patients with advanced gastric cancer. Seventeen pati

A phase II study of weekly cisplatin fol

A phase II study of weekly cisplatin followed by cisplatin and ifosfamide in advanced or recurrent cervical carcinoma

✍ Peter G. Rose; M. Steven Piver; John H. Malfetano; Trudy R. Baker; Ronald E. Hem 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 487 KB 👁 1 views

A phase II study of the combination of c

A phase II study of the combination of carboplatin and ifosfamide in previously untreated metastatic small cell lung carcinoma

✍ T. Le Chevalier; F. Thomas; R. Subirana; P. Baldeyrou; P. Ruffie; T. Tursz; R. A 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 317 KB 👁 1 views

Cis-platinum in treatment of advanced or

Cis-platinum in treatment of advanced or recurrent squamous cell carcinoma of the cervix: A phase ii study of the gynecologic oncology group

✍ Tate Thigpen; Hugh Shingleton; Howard Homesley; Leo Lagasse; John Blessing 📂 Article 📅 1981 🏛 John Wiley and Sons 🌐 English ⚖ 482 KB 👁 1 views

Gemcitabine, ifosfamide, cisplatin (GIP)

Gemcitabine, ifosfamide, cisplatin (GIP) for the treatment of advanced non-small cell lung cancer: A phase II study of the Italian oncology group for clinical research (goirc)

✍ C. Boni; G. Bisagni; L. Savoldi; G. Moretti; E. Rondini; M. Sassi; A. Zadro; T. 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 French ⚖ 55 KB 👁 1 views

A phase II study of carboplatin in child

A phase II study of carboplatin in children with recurrent or progressive solid tumors. A report from the childrens cancer group

✍ Lawrence J. Ettinger; Paul S. Gaynon; Mark D. Krailo; Ning Ru; Edward S. Baum; S 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 442 KB 👁 2 views

Background. Carboplatin is an analogue of cisplatin with less nonhematologic toxicity than